Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Recruiting · NCT05340491 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2026-05-11 | NCT05340491 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |
| Fujian Province Cancer Hospital | Fuzhou | China | 2 |
| Guizhou Cancer Hospital | Guiyang | China | 3 |
| Jiangxi Cancer Hospital | Nanchang | China | 18 |
| Peking University Third Hospital | Beijing | China | 71 |
| Sichuan Cancer Hospital | Chengdu | China | 21 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The First Affiliated Hospital of Guangxi Medical University | Nanning | China | 24 |
| The First Affiliated Hospital of Xiamen University | Xiamen | China | 40 |
| Xijing Hospital | Xi'an | China | 6 |
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |
| Zhongnan Hospital of Wuhan University | Wuhan | China | 18 |